🔍

Evexia Lifecare Ltd (524444)

📊 BSE: 524444 🏢 Trading - Chemicals 📢 Latest filing: 01 Oct 2026 📝 Analysis written: 13 Nov 2025

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Evexia Lifecare's revenue was ₹30.9 Cr (+39.8% year on year, -16.0% on the previous quarter), and net profit ₹0.4 Cr (-33.4% year on year); the operating margin was 1.7%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹30.9	+39.8%	-16.0%
Operating profit	₹0.5	-50.4%	-51.3%
Net profit	₹0.4	-33.4%	-46.2%
EPS (₹)	0.00	—	—
Operating margin	1.7%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Promoter Entity Shree Saibaba Exim Acquires 0.352% Stake in Evexia Lifecare for 66.25 Lakh Shares

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 01 Oct 2026, 04:04 PM

Promoter group entity Shree Saibaba Exim Private Limited purchased 66,25,997 equity shares (representing 0.352% of total equity) of Evexia Lifecare Limited via open market on September 30, 2026. Following this transaction, the entity's holding increased from 6.794% (12,75,49,827 shares) to 7.147% (13,41,75,824 shares). The total paid-up equity capital base of the target company stands at 187,73,28,995 shares of face value Re 1 each. This filing is made under SEBI PIT Regulation 7(2)(a) and SAST Regulation 29(2).

Acquisition of 66,25,997 equity shares (0.352% of voting capital) via open market
Pre-acquisition holding stood at 12,75,49,827 shares (6.794%)
Post-acquisition holding stands at 13,41,75,824 shares (7.147%)
Transaction executed on September 30, 2026 and disclosed on October 01, 2026

💡 Track quarterly shareholding pattern updates to assess whether promoter group entities continue small open-market purchases given the overall low baseline promoter holding (~3.4%).

Promoter Group Buys 42.42 Lakh Shares (0.225% Stake) of Evexia Lifecare via Open Market

🟢 POSITIVE ⭐ 3/10

ROUTINE 📅 29 Sep 2026, 05:30 PM

Promoter group entity Shree Saibaba Exim Private Limited purchased 42,42,111 equity shares (0.225% stake) of Evexia Lifecare Limited through the open market on September 29, 2026. Following this acquisition, the entity's stake increased from 6.568% (12,33,07,716 shares) to 6.794% (12,75,49,827 shares). The total diluted share capital of the company stands unchanged at 1,87,73,28,995 equity shares. While open market insider purchases are generally seen positively, the acquisition represents a small portion of the total share capital.

Promoter group entity Shree Saibaba Exim Private Limited acquired 42,42,111 equity shares on September 29, 2026
Acquisition represents 0.225% of total voting and paid-up share capital via open market
Pre-acquisition holding was 12,33,07,716 shares (6.568%)
Post-acquisition holding stands at 12,75,49,827 shares (6.794%)
Total share capital of the company is 187,73,28,995 equity shares of face value Re 1 each

💡 Track upcoming quarterly shareholding patterns to verify overall promoter and promoter group aggregate holding trends.

Promoter Entity Acquires 25.05 Lakh Shares (0.133% Stake) in Evexia Lifecare via Open Market

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 28 Sep 2026, 05:11 PM

Promoter group entity Shree Saibaba Exim Private Limited acquired 25,05,000 equity shares (0.133% stake) of Evexia Lifecare Limited via the open market on September 28, 2026. Following this purchase, the entity's stake increased from 6.434% (12,08,02,716 shares) to 6.568% (12,33,07,716 shares). The total equity capital of the company remains unchanged at 1,87,73,28,995 shares. Despite the purchase, overall promoter group holding remains extremely low, reported at approximately 3.4% in recent quarters.

Acquisition of 25,05,000 equity shares via open market on September 28, 2026
Acquired shares represent 0.133% of the total equity share capital
Acquirer's holding increased from 6.434% (12,08,02,716 shares) to 6.568% (12,33,07,716 shares)
Total voting capital of the company stands at 1,87,73,28,995 equity shares

💡 Monitor upcoming quarterly shareholding patterns to track whether aggregate promoter holding meaningfully increases from its current low base.

Promoter Group Acquires 8,57,000 Shares (0.045%) of Evexia Lifecare via Open Market

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 25 Sep 2026, 10:52 AM

Promoter group entity Shree Saibaba Exim Private Limited purchased 8,57,000 equity shares of Evexia Lifecare Limited via open market transactions on September 24, 2026. The acquisition represents approximately 0.045% of the total paid-up share capital. Following this purchase, the entity's holding increased from 11,99,45,716 shares (6.389%) to 12,08,02,716 shares (6.434%). At the market price of Rs 1.7, the transaction value stands at roughly Rs 0.15 crore, which is minor relative to the company's Rs 1,590 crore market cap.

Purchased 8,57,000 equity shares via open market on September 24, 2026
Acquisition represents 0.045% of the total equity capital
Promoter entity holding increased from 6.389% to 6.434%
Total post-acquisition holding stands at 12,08,02,716 equity shares
Transaction value reported in disclosure at Rs 12,08,000

💡 Track whether promoter group purchases continue in subsequent quarters and monitor quarterly shareholding pattern disclosures to see overall insider accumulation trends.

Promoter Group Acquires 50.33 Lakh Shares (0.268%) in Evexia Lifecare

🟢 POSITIVE ⭐ 3/10

ROUTINE 📅 23 Sep 2026, 05:24 PM

Promoter group entity Shree Saibaba Exim Private Limited purchased 50,33,131 equity shares of Evexia Lifecare via the open market on September 23, 2026. This acquisition represents 0.268% of the company's total voting capital. Following the transaction, the entity's holding increased from 6.121% (11,49,12,585 shares) to 6.389% (11,99,45,716 shares). The total paid-up equity share capital remains unchanged at 1,87,73,28,995 shares of Re 1 face value.

Acquisition of 50,33,131 equity shares representing 0.268% stake
Pre-acquisition holding was 11,49,12,585 shares or 6.121%
Post-acquisition holding increased to 11,99,45,716 shares or 6.389%
Transaction conducted via open market on September 23, 2026
Total share capital stands at 187,73,28,995 shares

💡 Track whether promoter group open-market purchases continue in subsequent shareholding disclosures.

Promoter Group Buys 14.45 Lakh Shares of Evexia Lifecare via Open Market

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 22 Sep 2026, 05:37 PM

Evexia Lifecare disclosed that promoter group entity Shree Saibaba Exim Private Limited purchased 14,45,000 equity shares via open market transactions on September 22, 2026. This acquisition represents 0.076% of the company's total voting capital. Following the transaction, Shree Saibaba Exim's shareholding increased from 6.044% (11,34,67,585 shares) to 6.121% (11,49,12,585 shares). The total equity capital of Evexia Lifecare remains unchanged at 1,87,73,28,995 equity shares.

Promoter group entity Shree Saibaba Exim acquired 14,45,000 equity shares via the open market on September 22, 2026
Acquisition represents 0.076% of total voting capital
Acquirer's holding rose from 11,34,67,585 shares (6.044%) to 11,49,12,585 shares (6.121%)
Total voting equity capital of the company stands at 1,87,73,28,995 shares of Re 1 face value

💡 Track periodic shareholding pattern filings to observe whether overall promoter group accumulation continues over upcoming quarters.

Promoter Group Buys 21.97 Lakh Shares (0.117% Stake) in Evexia Lifecare via Open Market

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 04 Sep 2026, 04:42 PM

Promoter group entity Shree Saibaba Exim Private Limited acquired 21,97,322 equity shares (0.117% stake) of Evexia Lifecare Limited through open market purchases on September 04, 2026. Following this transaction, the entity's holding increased from 2,37,39,624 shares (1.259%) to 2,59,36,946 shares (1.376%). The total equity share capital of the company stands at 187,73,28,995 equity shares of Re. 1 face value.

Promoter group entity Shree Saibaba Exim Private Limited purchased 21,97,322 equity shares on September 04, 2026
Acquisition represents 0.117% of the total diluted share capital of the company
Entity's stake increased from 1.259% (2,37,39,624 shares) to 1.376% (2,59,36,946 shares)
Transaction was executed via open market purchases

💡 Monitor quarterly shareholding patterns to track whether overall promoter holding (which stood at ~3.4%) sees sustained accumulation.

Evexia Lifecare Q1 PAT Falls 33% to ₹0.42 Cr; Auditor Flags ₹36.8 Cr Risky Receivables

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 07 Aug 2026, 07:18 PM

Evexia Lifecare reported a 39.8% YoY increase in consolidated revenue to ₹30.89 Cr for Q1 FY27, yet net profit declined 33.3% to ₹0.42 Cr. The company forfeited 24 crore convertible warrants, resulting in a ₹21.60 Cr transfer to Capital Reserves as the holders failed to pay the remaining 75% consideration. Most significantly, the statutory auditor issued a qualified opinion, highlighting ₹29.44 Cr in trade receivables and ₹7.35 Cr in loans with significant credit risk for which no provisions were made. A new EV mobility division was launched, contributing a negligible ₹2.72 Lakhs to the top line this quarter.

Consolidated revenue increased to ₹30.89 Cr from ₹22.09 Cr in the year-ago quarter.
Consolidated Net Profit dropped to ₹0.42 Cr from ₹0.63 Cr YoY.
Forfeited ₹21.60 Cr in warrant application money due to non-payment of the 75% balance by holders.
Auditor flagged ₹29.44 Cr of trade receivables and ₹7.35 Cr of loans as having significant credit risk without proper assessment.
New 'Go EVEXIA' EV rental division commenced operations with initial revenue of ₹2.72 Lakhs.

💡 Investors should closely monitor the recovery of the ₹36.79 Cr in flagged receivables and loans, as a write-off would significantly impact the company's net worth. The auditor's mention of 'material misstatements' and 'missing documentation' warrants extreme caution regarding internal controls.

Evexia Lifecare Q1 Revenue Up 40% YoY; Auditor Flags Rs 36.79 Cr in Risky Assets

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 07 Aug 2026, 07:11 PM

Evexia Lifecare reported a 39.8% YoY increase in consolidated revenue to Rs 30.89 Cr for Q1 FY27, though standalone net profit dipped to Rs 0.41 Cr from Rs 0.59 Cr. A major financial event occurred as the company forfeited 24 crore warrants, transferring Rs 21.60 Cr to capital reserves after holders failed to pay the remaining 75% consideration. Critically, the statutory auditor issued a qualified opinion, questioning the recoverability of Rs 29.44 Cr in trade receivables and Rs 7.35 Cr in loans. The company also launched its 'Go EVEXIA' EV mobility division, which contributed a marginal Rs 2.72 Lakhs in its debut quarter.

Consolidated revenue increased to Rs 30.89 Cr in Q1 FY27 from Rs 22.09 Cr in Q1 FY26
Forfeiture of 24,00,00,000 warrants resulted in Rs 21.60 Cr added to Capital Reserve
Auditor flagged Rs 29.44 Cr of trade receivables and Rs 7.35 Cr of loans as having significant credit risk without proper loss assessment
New EV mobility division 'Go EVEXIA' commenced operations with initial revenue of Rs 2.72 Lakhs
Standalone net profit for the quarter stood at Rs 41.49 Lakhs, down from Rs 58.69 Lakhs YoY

💡 Investors should closely monitor management's ability to recover the Rs 36.79 Cr in flagged receivables and loans, which represents over 30% of TTM revenue. The failure of warrant holders to exercise their options and the extremely low promoter holding (3.36%) are significant governance and liquidity signals.

Evexia Lifecare Board Meeting on Aug 07 to Approve Q1 FY27 Un-Audited Results

🟡 NEUTRAL ⭐ 2/10

BOARD_MEETING 📅 05 Aug 2026, 11:10 AM

Evexia Lifecare has issued a corrigendum for its board meeting scheduled for August 07, 2026. The meeting will consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. This filing corrects a clerical error in a previous notice dated August 04, 2026, which incorrectly stated the results would be 'Audited'. The company currently operates with a TTM revenue of Rs 110 Cr and a low net profit margin.

Board meeting scheduled for Friday, August 07, 2026.
Correction of previous intimation dated August 04, 2026 (Ref: 13786204).
Agenda includes approval of Un-Audited Financial Results for the quarter ended June 30, 2026.
Company reported TTM revenue of Rs 110 Cr and TTM PAT of Rs 2 Cr.

💡 Investors should watch for the actual financial results on August 07, 2026, to assess if the company can improve its thin operating margins (2.3% TTM).

Board Meeting on Aug 07, 2026 to Approve Q1 FY27 Audited Financial Results

🟡 NEUTRAL ⭐ 2/10

BOARD_MEETING 📅 04 Aug 2026, 05:53 PM

Evexia Lifecare has scheduled a board meeting for August 07, 2026, to consider and approve the audited financial results for the quarter ended June 30, 2026. The company currently operates with a TTM revenue of Rs 110 Cr and a thin net profit of Rs 2 Cr. Investors should note the company's high debt levels of Rs 1222 Cr relative to its net worth of Rs 567 Cr (D/E of 2.16). Additionally, promoter holding is critically low at 3.36%, making the upcoming quarterly performance key for assessing operational stability.

Board meeting scheduled for August 07, 2026, to review Q1 FY27 performance.
Results pertain to the three-month period ended June 30, 2026.
Trading window for insiders will remain closed until 48 hours after the results are made public.
Company reported a TTM operating profit margin of only 2.3% as of the last fiscal year.

💡 Monitor the Q1 FY27 results on August 07 for any signs of margin improvement or debt reduction strategies, given the high leverage and low promoter stake.

View All 524444 Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

The company operates in a single business segment; segment-wise revenue growth percentages are not disclosed in available documents.

Geographic Revenue Split

A major portion of the company's business is conducted abroad, but specific percentage splits between domestic and international regions are not disclosed.

Profitability Margins

Operating Profit Margin Ratio improved to 5.27% in FY24 from 4.00% in FY23 (+31.75% YoY). Net Profit Margin Ratio declined to 2.10% in FY24 from 2.89% in FY23 (-27.34% YoY).

EBITDA Margin

Operating Profit Margin is 5.27% for FY24, representing a 31.75% increase from the previous year's 4.00% due to favorable business circumstances.

Capital Expenditure

The company has curtailed expenditure substantially to manage market conditions; specific historical or planned capital expenditure values in INR Cr are not disclosed.

Credit Rating & Borrowing

The company issued Foreign Currency Convertible Bonds (FCCB), which led to an incremental finance cost and a 57.29% decrease in the Interest Coverage Ratio from 51.96 to 22.19.

⚙️ Operational Drivers

Raw Materials

Not disclosed in available documents as the company focuses on trading and commission-based activities.

Capacity Expansion

Not disclosed in available documents; the company is currently exploring trading and commission-based activities rather than manufacturing expansion.

Manufacturing Efficiency

Not disclosed in available documents; the Inventory Turnover Ratio was 0 in both FY24 and FY23.

📈 Strategic Growth

Growth Strategy

The company is exploring profitable trading and commission-based activities while substantially curtailing expenditure. It aims to leverage its board's expertise in business leadership and global experience to drive long-term growth and protect stakeholder interests.

Products & Services

Trading business activities and commission-based services.

Brand Portfolio

Evexia Lifecare Limited.

New Products/Services

The company is exploring new activities in the trading and commission-based segment, which currently appear profitable.

Market Expansion

The company conducts a major portion of its business abroad and complies with statutes in those countries to facilitate international presence.

🌍 External Factors

Industry Trends

The industry is seeing rapid expansion and increased competition, pushing companies to focus on core competencies and technology-driven transformation.

Competitive Landscape

The market is increasingly competitive due to the presence of unorganized players and recent regulatory compliance requirements.

Competitive Moat

The company relies on a foundation of good corporate governance, ethical business conduct, and a skilled board to deliver long-term stakeholder value.

Macro Economic Sensitivity

Operations are sensitive to economic conditions affecting global markets and changes in government regulations or tax laws.

Geopolitical Risks

As a major portion of business is conducted abroad, the company is exposed to international regulatory changes and trade statutes in multiple countries.

⚖️ Regulatory & Governance

Industry Regulations

The company must comply with SEBI (LODR) Regulations, the Companies Act 2013, and the statutes of various foreign countries where it maintains a presence.

Environmental Compliance

The Board monitors material effluent or pollution problems as part of its information access and oversight role.

Taxation Policy Impact

Changes in tax laws and other statutes are identified as important factors that could materially affect results.

Legal Contingencies

The Board monitors show cause, demand, prosecution, and penalty notices that are materially important, though specific pending case values are not disclosed.